Indies Pharma Sees Increase in Bottom-Line for Q1 2023
For the first quarter ending January 31, 2024, Indies Pharma Jamaica Ltd. reported a net profit of $62.49Mn (EPS: $0.047),…
Curated News for JSE listed companies
For the first quarter ending January 31, 2024, Indies Pharma Jamaica Ltd. reported a net profit of $62.49Mn (EPS: $0.047),…
https://www.jamstockex.com/indies-pharma-jamaica-limited-annual-report-2023-2/ https://www.jamstockex.com/indies-pharma-jamaica-limited-amendment-to-annual-report-2023/
In a robust fourth quarter ending October 2023, the pharma distributor improved its sales performance by 28 per cent… https://jamaica-gleaner.com/article/business/20231222/indies-pharma-hits-billion-dollar-milestone
https://www.jamstockex.com/indies-pharma-jamaica-limited-disclosure-of-new-product-release/
https://www.jamstockex.com/indies-pharma-jamaica-limited-disclosure-of-anda-filing-at-usfda-a-paragraph-iv-filing-and-patent-amendment/
Stocks to Watch 2023 Episode 3 featuring David Rose, Chike Verwey, Matthew Preston and Jermaine McDonald.https://www.youtube.com/watch?v=LgXj1bm2MdA
3 months Net Profit DOWN -63.6%, Revenue DOWN -7.6% vs last year 6 months Net Profit DOWN -23.1%, Revenue UP…
https://www.jamstockex.com/indies-pharma-jamaica-limited-annual-report-2022/
https://www.jamstockex.com/indies-pharma-jamaica-limited-indies-annual-report-2022/
3 months Net Profit UP 17.6%, Revenue UP 20.3% vs last year www.jamstockex.com/?tag=INDIES&category_name=quarterly-financial-statements